CD2BP2
Basic information
Region (hg38): 16:30350773-30355308
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD2BP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 22 | 22 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 0 | 0 |
Variants in CD2BP2
This is a list of pathogenic ClinVar variants found in the CD2BP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-30353016-G-C | not specified | Uncertain significance (Nov 17, 2022) | ||
16-30353044-C-A | not specified | Uncertain significance (May 21, 2024) | ||
16-30353197-G-A | not specified | Uncertain significance (Jan 06, 2023) | ||
16-30353201-A-C | not specified | Uncertain significance (Apr 07, 2022) | ||
16-30353273-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
16-30353278-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
16-30353409-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
16-30353461-G-C | not specified | Uncertain significance (Jan 09, 2024) | ||
16-30353491-G-C | not specified | Uncertain significance (Apr 06, 2024) | ||
16-30353494-G-A | not specified | Uncertain significance (Oct 22, 2021) | ||
16-30353502-A-C | not specified | Uncertain significance (Jan 17, 2024) | ||
16-30353568-G-A | not specified | Uncertain significance (Apr 06, 2024) | ||
16-30353575-G-A | not specified | Uncertain significance (Dec 06, 2022) | ||
16-30353616-C-T | not specified | Uncertain significance (May 02, 2024) | ||
16-30353647-G-C | not specified | Uncertain significance (Dec 16, 2022) | ||
16-30353686-G-A | not specified | Uncertain significance (Mar 27, 2023) | ||
16-30353706-A-G | not specified | Uncertain significance (May 23, 2024) | ||
16-30353744-C-A | not specified | Uncertain significance (Apr 18, 2023) | ||
16-30353754-G-A | not specified | Uncertain significance (Apr 25, 2022) | ||
16-30353790-C-T | not specified | Uncertain significance (Aug 02, 2022) | ||
16-30353915-C-A | not specified | Uncertain significance (Jul 13, 2021) | ||
16-30354017-T-C | not specified | Uncertain significance (Feb 16, 2023) | ||
16-30354020-G-A | not specified | Uncertain significance (Apr 19, 2023) | ||
16-30354201-G-A | not specified | Uncertain significance (Apr 09, 2024) | ||
16-30354238-C-G | not specified | Uncertain significance (Apr 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD2BP2 | protein_coding | protein_coding | ENST00000305596 | 6 | 4596 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000152 | 0.870 | 125713 | 0 | 35 | 125748 | 0.000139 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.559 | 233 | 210 | 1.11 | 0.0000129 | 2209 |
Missense in Polyphen | 53 | 55.736 | 0.95091 | 644 | ||
Synonymous | -2.88 | 117 | 83.5 | 1.40 | 0.00000486 | 680 |
Loss of Function | 1.46 | 10 | 16.4 | 0.612 | 8.70e-7 | 184 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000291 | 0.0000291 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000273 | 0.000272 |
Finnish | 0.000323 | 0.000323 |
European (Non-Finnish) | 0.000141 | 0.000141 |
Middle Eastern | 0.000273 | 0.000272 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in pre-mRNA splicing as component of the U5 snRNP complex that is involved in spliceosome assembly. {ECO:0000269|PubMed:15840814}.;
- Pathway
- mRNA Processing;Metabolism of RNA;mRNA Splicing - Major Pathway;mRNA Splicing;Processing of Capped Intron-Containing Pre-mRNA
(Consensus)
Recessive Scores
- pRec
- 0.125
Intolerance Scores
- loftool
- 0.597
- rvis_EVS
- 0.06
- rvis_percentile_EVS
- 58.74
Haploinsufficiency Scores
- pHI
- 0.334
- hipred
- Y
- hipred_score
- 0.595
- ghis
- 0.499
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.668
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cd2bp2
- Phenotype
Gene ontology
- Biological process
- spliceosomal tri-snRNP complex assembly;mRNA splicing, via spliceosome;negative regulation of phosphatase activity
- Cellular component
- fibrillar center;nucleus;nucleoplasm;U5 snRNP;cytoplasm;cytosol;nuclear speck;U4/U6 x U5 tri-snRNP complex
- Molecular function
- protein binding;ribonucleoprotein complex binding